From screening to treatment: in vitro and in vivo efficacy of phage-meropenem combination against highly virulent Carbapenem-resistant Acinetobacter baumannii
Open Access
- 7 July 2026
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0396225
Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a hospital-acquired pathogen of significant clinical importance. Given the slow progress in antibiotic development, phages have emerged as a novel therapeutic strategy against CRAB infections due to their synergistic effects with antibiotics. This study aims to explore phage-antibiotic combination therapy targeting CRAB, thereby providing a theoretical foundation for its clinical translation. Through virulence assessments in Galleria mellonella larvae and mice, CRAB110 was identified as the most virulent strain among 199 clinical CRAB isolates. Transcription analysis revealed that its enhanced pathogenicity may be associated with dysregulated pro-inflammatory responses. Using CRAB110 as the host bacterium, the newly isolated phage, P2, was selected for further study due to its high lytic efficiency and broad host range. The CRAB110 mutant strain CRAB110-2N, treated with P2, exhibited increased drug susceptibility and attenuated virulence compared to the wild-type strain. Both in vitro and in vivo experiments demonstrated that the combination of P2 with antibiotics achieved superior bacterial clearance compared to phage therapy alone. Furthermore, whole-genome analysis of CRAB110-2N revealed a mutation in its ugd . The constructed CRAB110Δ ugd showed tolerance to P2; the quorum-sensing gene abaI was associated with phage susceptibility, with the CRAB110Δ abaI strain displaying insensitivity to P2. These findings provide experimental evidence supporting the clinical application of phage-antibiotic combination therapy. IMPORTANCE: This study focused on phage-antibiotic combination therapy targeting carbapenem-resistant Acinetobacter baumannii (CRAB), a priority pathogen designated by the World Health Organization (WHO). A highly virulent strain, CRAB110, was screened from 199 clinical isolates, and a novel, highly lytic phage, P2, was isolated from sewage samples. CRAB110-2N, a mutant strain induced by P2 exposure, displayed increased antibiotic susceptibility and attenuated virulence. Key findings showed that the combination of P2 and meropenem achieved a 99% bacterial clearance rate in vitro and exerted significant synergistic effects in vivo . Genomic analysis identified mutations in the ugd gene, and knockout experiments confirmed its correlation with phage susceptibility. Additionally, the quorum-sensing gene abaI was found to be associated with phage susceptibility in CRAB. Collectively, these results provide critical experimental evidence for the clinical translation of this phage-antibiotic combination therapy.Keywords
Funding Information
- the Guizhou Key Laboratory of Microbiome and Infction Disease Pervention& Control, China (ZDSYS [2023] 004)
- the Natural Science Foundation of Guizhou Province (ZK [2021] Zhongdian 030,ZK [2022] Key Programo39)
- QKH Basic MS ([2025]555,ZK[2022] General 349)
- Engineering Research Center of Health Medicine biotechnology of Institution of higher education of Guizhou Province (Qian Jiao Ji No[2023]036)
- the High-Level Talent Initiation Province of Guizhou Medical University (J[2022]023)
- undergraduate innovation and entrepreneurship project (S202310660074,S202410660556,S2024106601292,S202310660080)
This publication has 78 references indexed in Scilit:
- Microbial quorum sensing: Mechanisms, applications, and challengesBiotechnology Advances, 2025
- Quorum Sensing: Not Just a Bridge Between BacteriaMicrobiologyopen, 2025
- Bioorganic compounds in quorum sensing disruption: strategies, Mechanisms, and future prospectsBioorganic Chemistry, 2025
- Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogensCell, 2024
- Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory StrategyReviews in Medical Virology, 2024
- Cross-species communication via agr controls phage susceptibility in Staphylococcus aureusCell Reports, 2023
- Phage therapy: From biological mechanisms to future directionsCell, 2023
- Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia modelMedical Microbiology and Immunology, 2022
- In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infectionsClinical Microbiology and Infection, 2022
- A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent miceClinical Microbiology and Infection, 2019